IL17A and rheumatoid arthritis: JNJ-54271074, another RORγt inverse agonist, inhibits IL-17 and IL-22 production in murine Th17, Tγδ, and NKT cells and, remarkably, in peripheral blood mononuclear cells (PBMC) obtained from rheumatoid arthritis patients [158] (Table 1).